ArticleFrontiers in oncology2022

Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma.

Guangyao Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.